» Authors » E Qadeer

E Qadeer

Explore the profile of E Qadeer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 121
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fatima R, Yaqoob A, Qadeer E, Khan M, Ghafoor A, Jamil B, et al.
Int J Tuberc Lung Dis . 2022 Sep; 26(10):929-933. PMID: 36163662
Multidrug-resistant TB (MDR-TB) treatment takes 18-24 months and is complex, costly and isolating. We provide trial evidence on the WHO Pakistan recommendation for community-based care rather than hospital-based care. Two-arm,...
2.
Waheed Y, Khan M, Fatima R, Yaqoob A, Mirza A, Qadeer E, et al.
Public Health Action . 2017 Aug; 7(1):26-31. PMID: 28775940
Ten hospitals managing drug-resistant tuberculosis (TB) in Pakistan. To assess the implementation of TB infection control (IC) practices and reasons for non-adherence to guidelines. This was a descriptive study conducted...
3.
Wali A, Kumar A, Hinderaker S, Heldal E, Qadeer E, Fatima R, et al.
Public Health Action . 2017 Aug; 7(1):21-25. PMID: 28775939
Three public sector tertiary care hospitals in Quetta, Balochistan, Pakistan, with anecdotal evidence of gaps between the diagnosis and treatment of patients with tuberculosis (TB). To assess the proportion of...
4.
Aslam W, Tahseen S, Schomotzer C, Hussain A, Khanzada F, Ul Haq M, et al.
Public Health Action . 2017 Jul; 7(2):141-146. PMID: 28695088
Adult pulmonary tuberculosis (TB) patients unable to expectorate quality sputum represent a diagnostic challenge. A private hospital in Pakistan routinely performs gastric aspiration in adults with difficulties expectorating. To assess...
5.
Javaid A, Hasan R, Zafar A, Chaudry M, Qayyum S, Qadeer E, et al.
Int J Tuberc Lung Dis . 2017 Feb; 21(3):303-308. PMID: 28225340
Background: Drug resistance in general, and multidrug-resistant tuberculosis (MDR-TB) in particular, threatens global tuberculosis (TB) control efforts. Population-based estimates of drug resistance are needed to develop strategies for controlling drug-resistant...
6.
Tahseen S, Qadeer E, Khanzada F, Rizvi A, Dean A, Van Deun A, et al.
Int J Tuberc Lung Dis . 2016 Mar; 20(4):448-55. PMID: 26970152
Setting: The first national anti-tuberculosis drug resistance survey in Pakistan, a high tuberculosis (TB) and low human immunodeficiency virus (HIV) burden country. Objective: To determine the proportion of patients with...
7.
Fatima R, Qadeer E, Enarson D, Hinderaker S, Harris R, Yaqoob A, et al.
Public Health Action . 2015 Sep; 4(2):110-2. PMID: 26399209
Pakistan's National Tuberculosis Control Programme (NTP) is missing data on many tuberculosis (TB) cases who visit private providers. A survey on the incidence and under-reporting of TB in Pakistan provided...
8.
Shah S, Kumar A, Dogar O, Khan M, Qadeer E, Tahseen S, et al.
Public Health Action . 2015 Sep; 3(1):20-2. PMID: 26392990
Xpert(®) MTB/RIF testing was offered to consecutive patients with presumptive tuberculosis (TB) attending two hospitals in Pakistan during April-May 2012, in addition to routine diagnostic protocol (smear microscopy, chest radiography...
9.
Fatima R, Qadeer E, Hinderaker S, Yaqoob A, Enarson D, Bassili A, et al.
Int J Tuberc Lung Dis . 2015 May; 19(6):654-6. PMID: 25946354
The frequency of patients with presumptive tuberculosis (TB) who are not investigated by sputum smear microscopy is unknown in Pakistan. Using a simple intervention comparing patient and laboratory registers, patients...
10.
Fatima R, Qadeer E, Enarson D, Creswell J, Stevens R, Stevens R, et al.
Int J Tuberc Lung Dis . 2014 Sep; 18(9):1099-104. PMID: 25189559
Background: In Pakistan, patients with symptoms suggestive of tuberculosis (TB) seek care from a wide array of health care providers, many of whom do not notify cases to the National...